Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Polman

Showing results (41-50 of 290) with videos related to

Pageof 29
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot studyN F Kalkers, F Barkhof, E Bergers, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 5, 1999
A comparison of responsiveness indices in multiple sclerosis patientsL E Pfennings, H M van der Ploeg, L Cohen, et al.
Journal of Neuroimmunology|July 1, 1996
Recombinant interferon-beta blocks proliferation but enhances interleukin-10 secretion by activated human T-cellsM H Rep, R Q Hintzen, C H Polman, et al.
Neurosurgery|September 1, 1986
Rapid spontaneous resolution of an acute subdural hematomaC H Polman, C J Gijsbers, J J Heimans, et al.
Neurology|August 28, 2002
Quantitative functional measures in MS: what is a reliable change?B M J Uitdehaag, H J Adèr, N F Kalkers, et al.
Clinical Neurology and Neurosurgery|January 1, 1988
Neuromyelitis optica (Devic's syndrome): not always multiple sclerosisA J Breukelman, C H Polman, R G de Slegte, et al.
Acta Neurologica Scandinavica|October 1, 1994
Effect of K+ channel blockers on the clinical course and histological features of experimental allergic encephalomyelitisB M Uitdehaag, C H Polman, C J de Groot, et al.
Archives of Neurology|March 1, 1994
4-aminopyridine in the treatment of patients with multiple sclerosis. Long-term efficacy and safetyC H Polman, F W Bertelsmann, A C van Loenen, et al.
Journal of Neuroimmunology|July 1, 1992
Multiple sclerosis: immunological findings and possible implications for therapyR Q Hintzen, C H Polman, C J Lucas, et al.
Neurology|September 29, 2004
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment SubcommitteeB M J Uitdehaag, J J G Geurts, F Barkhof, et al.
Pageof 29

Showing results (41-50 of 290) with videos related to

Sort By:
Pageof 29
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot studyN F Kalkers, F Barkhof, E Bergers, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 5, 1999
A comparison of responsiveness indices in multiple sclerosis patientsL E Pfennings, H M van der Ploeg, L Cohen, et al.
Journal of Neuroimmunology|July 1, 1996
Recombinant interferon-beta blocks proliferation but enhances interleukin-10 secretion by activated human T-cellsM H Rep, R Q Hintzen, C H Polman, et al.
Neurosurgery|September 1, 1986
Rapid spontaneous resolution of an acute subdural hematomaC H Polman, C J Gijsbers, J J Heimans, et al.
Neurology|August 28, 2002
Quantitative functional measures in MS: what is a reliable change?B M J Uitdehaag, H J Adèr, N F Kalkers, et al.
Clinical Neurology and Neurosurgery|January 1, 1988
Neuromyelitis optica (Devic's syndrome): not always multiple sclerosisA J Breukelman, C H Polman, R G de Slegte, et al.
Acta Neurologica Scandinavica|October 1, 1994
Effect of K+ channel blockers on the clinical course and histological features of experimental allergic encephalomyelitisB M Uitdehaag, C H Polman, C J de Groot, et al.
Archives of Neurology|March 1, 1994
4-aminopyridine in the treatment of patients with multiple sclerosis. Long-term efficacy and safetyC H Polman, F W Bertelsmann, A C van Loenen, et al.
Journal of Neuroimmunology|July 1, 1992
Multiple sclerosis: immunological findings and possible implications for therapyR Q Hintzen, C H Polman, C J Lucas, et al.
Neurology|September 29, 2004
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment SubcommitteeB M J Uitdehaag, J J G Geurts, F Barkhof, et al.
Pageof 29